Laparoscopic Sacrocolpexy Versus Lateral Suspension (SUSPENSION)
Laparoscopic Sacrocolpexy Versus Lateral Suspension With a Mesh for the Treatment of Pelvic Organ Prolapse : a Randomized Controlled Trial
Surgical treatment of genital prolapse can be performed by laparoscopic surgery or by vaginal surgery, with or without using meshes. Laparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall and the promontory is the gold standard procedure to treat anterior prolapse or of the vaginal vault. Most of studies shows a success rate of 80% of this procedure.
However, access to the promontory could be difficult in patients because of adherences or anatomical reasons. This step of the procedure also exposes to risk of ureteral or vascular injuries. Recent issues have also found spondylodiscitis cases.
The technique of laparoscopic lateral suspension with mesh was developed by Dubuisson in 1998 allows not to have to approach the promontory and avoids both the risk of vascular injury and ureteral damage of laparoscopic sacrocolpopexy. Instead of attach the mesh to the promontory, the procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall. The aim of this study is to compare the clinical and functional efficiency of the lateral suspension versus laparoscopic sacrocolpopexy.
It is a prospective, randomized, monocentric study compared two groups The study hypothesis is that the lateral suspension would provide correction than the laparoscopic sacrocolpopexy.
The primary outcome is the comparison of anatomic correction rates at 1 year Success is defined as 1 year Ba et C points < -1 centimeter in POP-Q international score.
Secondary endpoints are improve of quality of life evaluated with the validated P-QOL questionnaire, and complications rates, including post-operative posterior prolapse.
Number of subjects required is 72 patients, 36 in each group having a laparoscopic sacrocolpopexy or lateral suspension.
Outcomes will be evaluated at 1 month and 1 year post-operative consultation
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hôpitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients at least 18 years old.
- Patients who agreed to participate in the study and signed informed consent.
- Patient affiliated to a social protection system.
- Surgical indication by laparoscopy of prolapse cure symptomatic of the anterior stage and / or isolated medium.
Exclusion Criteria:
- Minor patient.
- Patient refusing to sign the consent or unable to receive the necessary information to give informed consent.
- Patient not affiliated to a social protection system.
- Presence of one or more contraindication (s) to laparoscopy
- Presence of posterior prolapse requiring surgical treatment
- Need for an associated surgical procedure.
- Major people under legal protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: promontory
Laparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall
|
Laparoscopy performed according to the usual technique of the participating center with pneumoperitoneum between 12 and 15 mmHg.
Placement of the 5 mm trocar operator left and right iliac fossa and 5 mm pubic addition.
|
|
Active Comparator: laparoscopic lateral suspension
The procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall
|
Laparoscopy performed according to the usual technique of the participating center with pneumoperitoneum between 12 and 15 mmHg.
Placement of the 5 mm trocar operator left and right iliac fossa and 5 mm pubic addition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate cervico-urethral hypermobility
Time Frame: one year
|
Success is defined by two points inferior at 1 centimeter in Pelvic organs prolapse quantification (POP-Q) international score.
defining a symptomatic or asymptomatic state
|
one year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-43
- 2017-A02650-53 (Registry Identifier: ID RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.